RNS Number : 0168D
Cambridge Nutritional Sciences PLC
01 April 2025
 

Cambridge Nutritional Sciences plc

(the 'Company' or 'CNS')

 

Appointment of Chief Executive Officer

Cambridge Nutritional Sciences plc (AIM: CNSL), the specialist medical diagnostics company focused on promoting a personalised and functional approach to health and nutrition ("the Company") is pleased to announce that Mr. James Cooper, currently serving as Interim Chief Executive Officer, has been offered the permanent role as the Chief Executive Officer of the Company, effective 31st March 2025.

Following the resignation of the prior CEO Mr. Jag Grewal and his subsequent departure from the Board in August 2024, James Cooper, who previously held the position of Chief Operating Officer, was appointed as Interim Chief Executive Officer. Since his appointment, James Cooper has impressed the Board with his strong operational leadership, building a solid foundation to deliver on our strategic objectives to deliver profitable growth for Shareholders over the coming years

Cally Rand, Chair of CNSL, comments:

 

"I'm delighted that James has agreed to take on the role permanently and I look forward to seeing the changes he will bring forward to strengthen the business".

 

The Board looks forward to James' continued leadership and the positive impact he will have on the Company's future growth and success.

For further information, please contact:

 

Contacts: 

 

Cambridge Nutritional Sciences plc

  www.cnsplc.com

Carolyn Rand, Non-Executive Chair


James Cooper, Chief Executive Officer




Cavendish Capital Markets Limited  

Tel: 020 7220 0500

Geoff Nash / Edward Whiley (Corporate Finance)


Nigel Birks / Harriet Ward (ECM)












 

About Cambridge Nutritional Sciences plc

Cambridge Nutritional Sciences plc (AIM: CNSL) is a specialist medical diagnostics company focused on industry-leading Health and Nutrition products.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAWPUQGWUPAGMG